Conference abstractPublished 20 Jun 2016
Genetic insight into antibiotic resistance reversion in multidrug resistant tuberculosis by iodine-containing nanomolecular complex FS-1
Associate Professor in the Centre for Bioinformatics and Computational Biology
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Drug induced reversion of antibiotic resistance is considered as a promising way to combat multidrug resistant infection that nowadays became a major threat to human health. Despite a general recognition of this opportunity, little studies were performed in the world to elucidate this phenomenon mainly because of the lack of reliable experimental models. An innovative anti-tuberculosis drug FS-1 was accepted for clinical use in Kazakhstan in 2015. Clinical trials and in vitro experiments revealed ability of this drug to induce reversion of antibiotic resistance in MDR-TB. A series of experiments on laboratory animals infected with the MDR-TB strain Mycobacterium tuberculosis SCAID 187.0 was performed for a systemic study of the drug resistance reversion phenomenon. The initial strain SCAID 187.0 was sequenced and the complete genome was deposited in NCBI (CP012506.1). Multiple Mtb isolates were collected at different stages of the experiment from the animals treated with traditional antibiotics with antibiotics supplemented with FS-1 in different concentrations and those which were left without treatment. The Mtb isolates were sequenced by Illumina and variant calling was performed. Bioinformatic analysis of the trends of genomic changes confirmed the theoretically predicted induced synergy mechanism of the drug resistance reversion. To our best knowledge, this experiment was the first systemic study of the drug resistance reversion phenomenon.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- SubjectInfectious Diseases
- SubjectMicrobiology
- BylineArticles whose byline prints “Oleg Reva”
